Skip to main content
OpenTrials
Completed

NCT Number: NCT01202617

Seroquel XR in the Long Term Treatment of Schizophrenia

The purpose of the study is to determine whether the Seroquel XR treatment for 6 months improves the relapse prevention in schizophrenic outpatients

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Relapse in Schizophrenia Mental Disorders Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Baja, Hungary

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • schizophrenic outpatients on at least 600 mg Seroquel XR treatment for at least 1 month

Exclusion criteria

  • Severe cerebro- and cardiovascular disease, severe hepatic impairment, gravidity

Treatment and study plan

Primary outcomes

  1. Rate of patients remained relapse free after 6 months of treatment

    Time frame: on the 60th day of treatment

  2. Rate of patients remained relapse free after 6 months of treatment

    Time frame: on the 180th day of treatment

Secondary outcomes

  1. connection between relapse and affective symptoms

    Time frame: on the 60th day of treatment

  2. connection between relapse and affective symptoms

    Time frame: 180th day of treatment

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Seroquel XR in the Long Term Treatment of Schizophrenia Focus on Affective Symptoms

Acronym: SereNIS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Sep 16, 2010
Registry last updated
Oct 24, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.